| Date Filed | Type | Description |
| 07/03/2023 |
4
| HENNEY CHRISTOPHER S (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 21,219 shares
@ $0
Granted 42,438 options to buy
@ $0.5891, valued at
$25k
|
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/22/2020 |
4
| HENNEY CHRISTOPHER S (Director) has filed a Form 4 on Prothena Corp plc|
Txns:
| Granted 17,500 options to buy
@ $11.33, valued at
$198.3k
|
|
| 05/31/2019 |
4
| HENNEY CHRISTOPHER S (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 18,750 options to buy
@ $0.64, valued at
$12k
|
|
| 05/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2018 |
4
| HENNEY CHRISTOPHER S (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 8,576 options to buy
@ $1.42, valued at
$12.2k
|
|
| 05/18/2018 |
4
| HENNEY CHRISTOPHER S (Director) has filed a Form 4 on Prothena Corp plc|
Txns:
| Granted 12,000 options to buy
@ $16.43, valued at
$197.2k
|
|
| 03/13/2018 |
4
| HENNEY CHRISTOPHER S (Director) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Unknown transaction of 60,185 shares
@ $0
Disposed/sold 25,000 options to buy
@ $6.36, valued at
$159k
Disposed/sold 13,927 restricted stock units
@ $0 |
|
| 01/09/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/29/2017 |
4
| HENNEY CHRISTOPHER S (Director) has filed a Form 4 on Prothena Corp plc|
Txns:
| Sold 900 shares
@ $70, valued at
$63k
Exercised 900 options to buy
@ $6.65, valued at
$6k
|
|
| 09/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2017 |
4
| HENNEY CHRISTOPHER S (Director) has filed a Form 4 on Prothena Corp plc|
Txns:
| Sold 5,000 shares
@ $66.1341, valued at
$330.7k
Exercised 5,000 options to buy
@ $6.65, valued at
$33.3k
|
|
| 06/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/19/2017 |
4
| HENNEY CHRISTOPHER S (Director) has filed a Form 4 on Prothena Corp plc|
Txns:
| Granted 12,000 options to buy
@ $56.23, valued at
$674.8k
|
|
| 03/01/2017 |
4
| HENNEY CHRISTOPHER S (Director) has filed a Form 4 on Prothena Corp plc |
| 02/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/10/2017 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities |
| 02/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/08/2016 |
4
| HENNEY CHRISTOPHER S (Director) has filed a Form 4 on Anthera Pharmaceuticals Inc |
| 08/05/2016 |
4/A
| HENNEY CHRISTOPHER S (Director) has filed a Form 4 on Prothena Corp plc |
| 06/28/2016 |
4
| HENNEY CHRISTOPHER S (Interim CEO and President) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Granted 54,347 options to buy
@ $0 |
|
| 05/31/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/24/2016 |
4
| HENNEY CHRISTOPHER S (Director) has filed a Form 4 on Prothena Corp plc|
Txns:
| Granted 15,000 options to buy
@ $42.5, valued at
$637.5k
|
|
| 04/29/2016 |
4
| HENNEY CHRISTOPHER S (Director) has filed a Form 4 on Anthera Pharmaceuticals Inc|
Txns:
| Granted 62,069 options to buy
@ $3.8, valued at
$235.9k
|
|
| 03/16/2016 |
4
| HENNEY CHRISTOPHER S (Interim CEO and President) has filed a Form 4 on Oncothyreon Inc.|
Txns:
| Granted 150,000 options to buy
@ $1.06, valued at
$159k
|
|
|